An Open-Label Extension Study to Assess the Long-term Effect of EDG-5506 on Safety,
Biomarkers, and Functional Measures in Adults and Adolescents with Becker Muscular
Dystrophy
Eligibility of study
You may be eligible for this study if you meet the following criteria: